STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Gold River Prod SEC Filings

GRPS OTC

Welcome to our dedicated page for Gold River Prod SEC filings (Ticker: GRPS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Want to see whether rising feed costs or new USDA export permits are moving Gold River Prod (GRPS) shares? Start with the filings investors search for first. This page gathers every Gold River Prod insider trading Form 4 transactions notice, each Gold River Prod quarterly earnings report 10-Q filing, and the full annual report so you can follow the company’s sustainable shrimp-farming story without hunting through EDGAR.

Stock Titan’s AI reads the documents alongside you. It creates plain-English explanations, surfaces material events from the latest Gold River Prod 8-K material events explained, and delivers Gold River Prod Form 4 insider transactions real-time alerts the moment executives trade stock. If you have ever typed “understanding Gold River Prod SEC documents with AI,” you will appreciate summaries that flag broodstock revenue trends, bio-asset fair-value changes, and pending environmental disclosures.

Dig deeper: a click on the 10-K reveals a section titled “Biological Assets,” already distilled by our platform so you can see cap-ex needs and export-permit status—true Gold River Prod annual report 10-K simplified. Need a quick look at margins? The AI highlights quarter-over-quarter shifts inside the Gold River Prod earnings report filing analysis. Governance matters are covered too: the latest Gold River Prod proxy statement executive compensation spells out incentive plans, while Gold River Prod executive stock transactions Form 4 help you spot buying patterns before the next harvest cycle. Complex aquaculture disclosures become actionable knowledge, giving you time to compare sustainability metrics rather than scroll through PDFs. All filings, all forms, updated in real time—explained simply.

Rhea-AI Summary

Trans American Aquaculture, Inc. (GRPS) filed a Form 12b-25, notifying a late filing of its Form 10-Q for the period ended September 30, 2025. The company cites that it has been unable to complete the review process with its auditor.

Form 12b-25 is a standard notice used when a registrant cannot meet a filing deadline. The narrative identifies the audit review as the cause of delay, without additional financial details.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Trans American Aquaculture, Inc. filed Amendment No. 1 to its Q2 2025 Form 10‑Q to revise the Balance Sheet and Statements of Stockholders’ Equity, reconciling the common stock issued value to the appropriate prior quarter and making a minor reclassification to a preferred stock to be issued line; it also furnishes XBRL Exhibit 101. No other changes to the original report.

Operations remain limited: Q2 2025 revenue was $0 (vs. $5,019 in Q2 2024) and net loss was $204,038. For the six months ended June 30, 2025, revenue was $0 (vs. $315,145 in 2024) and net loss was $317,745 (vs. $568,332). Cash was $198 at June 30, 2025, with current assets of $303,323 and current liabilities of $4,654,029, a working capital deficit of $4,350,706. Shares outstanding were 1,805,926,955 as of October 9, 2025.

The company discloses a going concern uncertainty and a voluntary Chapter 11 filing in December 2024, with a plan confirmation hearing scheduled for August 18, 2025. Management also reports a material weakness in internal control over financial reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Trans American Aquaculture (GRPS) filed its quarterly report, highlighting continued operating losses and liquidity stress. The company reported $0 revenue for both the three and six months ended June 30, 2025, with net losses of $204,038 and $317,745, respectively. Cash was $198 at quarter‑end, and current liabilities exceeded current assets by $4,350,706, indicating a significant working capital deficit.

The company remains under Chapter 11 protection following a December 2024 filing, with a plan confirmation hearing scheduled for August 18, 2025. Operations are paused; the company is maintaining broodstock only. Inventory totaled $302,409, primarily broodstock. Interest expense fell year over year, aiding a narrower loss.

To access funding, the company continued using preferred stock and warrant issuances with GHS, and it also disclosed an equity financing agreement that permits periodic common stock “puts.” Shares outstanding were 1,805,926,955 as of October 9, 2025. Management disclosed a going concern uncertainty and material weakness in internal control over financial reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Gold River Prod (GRPS)?

The current stock price of Gold River Prod (GRPS) is $0.00025 as of November 14, 2025.

What is the market cap of Gold River Prod (GRPS)?

The market cap of Gold River Prod (GRPS) is approximately 549.7K.
Gold River Prod

OTC:GRPS

GRPS Rankings

GRPS Stock Data

549.66k
1.24B
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Dallas